Salta al contenuto principale
Home

Dedicated to discovery

  • A proposito di ELGA
    • A proposito di ELGA
    • Carriere
    • Eventi
  • Supporto
    • Progettazione del laboratorio
  • Contatti
  • EN
  • DE
  • ES
  • FR
  • PT
  • EN-US
Home
  • Prodotti
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY® 30
    • ELGA Gamma Completa di Prodotti
  • Applicazioni
    • Analisi microbiologica
    • Biochimica clinica
    • Colture cellulari
    • Cromatografia liquida
      • High Performance Liquid Chromatography
    • Elettrochimica
    • Gascromatografia
    • Genetica
    • High Performance Liquid Chromatography (HPLC)
    • Immunochimica
    • Requisiti dell'acqua per laboratori generici
    • Spettrofotometria
    • Spettrometria di massa
    • Spettroscopia atomica
  • Tecnologie
    • Carbone attivo
    • Electrodeionization (EDI)
    • Filtrazione
    • Lampada UV
    • Osmosi inversa (RO)
    • PureSure
    • Scambio ionico
  • Impurità nell'acqua
    • Composti inorganici
    • Composti organici
    • Gas disciolti
    • Microorganismi e batteri
    • Partcolati
  • Conoscenza
    • BROSCHÜREN
    • Blog
    • Casi di studio
    • Acqua ultrapura
    • Guide e white paper
  • Dove acquistarli
  • Contattaci
Home
  • Contattaci
  • Prodotti
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY® 30
    • ELGA Gamma Completa di Prodotti
  • Applicazioni
    • Analisi microbiologica
    • Biochimica clinica
    • Colture cellulari
    • Cromatografia liquida
      • High Performance Liquid Chromatography
    • Elettrochimica
    • Gascromatografia
    • Genetica
    • High Performance Liquid Chromatography (HPLC)
    • Immunochimica
    • Requisiti dell'acqua per laboratori generici
    • Spettrofotometria
    • Spettrometria di massa
    • Spettroscopia atomica
  • Tecnologie
    • Carbone attivo
    • Electrodeionization (EDI)
    • Filtrazione
    • Lampada UV
    • Osmosi inversa (RO)
    • PureSure
    • Scambio ionico
  • Impurità nell'acqua
    • Composti inorganici
    • Composti organici
    • Gas disciolti
    • Microorganismi e batteri
    • Partcolati
  • Conoscenza
    • BROSCHÜREN
    • Blog
    • Casi di studio
    • Acqua ultrapura
    • Guide e white paper
  • Dove acquistarli
  • Contattaci
  • A proposito di ELGA
    • A proposito di ELGA
    • Carriere
    • Eventi
  • Supporto
    • Progettazione del laboratorio
  • Contatti
  • EN
  • DE
  • ES
  • FR
  • PT
  • EN-US
  • Informazioni sull'acqua ultrapura
  • Guide e White Paper
  • Dichiarazioni di conformità legale globale
  • Brevetti
  • Trademarks
  • Impressum
  • Printing Personalised Doses of Medical Cannabis - Finland
Clinical & Pharma
Science of the Future

Printing Personalised Doses of Medical Cannabis - Finland

12 Apr 2021
- by ELGA Editorial Team

medical cannabis

Medical cannabis is an effective treatment for various diseases, however, doses are highly individual and need to be closely monitored to avoid misuse. Researchers at Åbo Akademi University, Finland, and the University of Copenhagen, Denmark, have used UPLC to evaluate the concentration of cannabinoids in printed edible pharmaceuticals, to develop highly personalised drug products.

Medical cannabis has been shown to be effective in providing relief for various diseases, such as multiple sclerosis, that have not been successfully treated with other registered drugs currently available. As a result, many countries have recently legalised medical cannabis or introduced pilot programmes to evaluate the risks and benefits of legalisation for medical purposes. However, the dose required is highly individual, and treatment needs to be closely supervised to avoid undesired side effects, feeling ‘high’ or dependency resulting from long-term use. In addition, the patient’s cannabis consumption needs to be monitored and the minimum effective dose given, to avoid abuse or non-medical use, particularly as cannabis is still a registered class A drug in some parts of the world. Mass customisation is a suggested manufacturing model that integrates critical patient information, such as treatment dose, into mass production pipelines, to produce highly personalised drug products. Individual patterns of quick-response (QR) codes can be printed onto products to allow the production of pharmaceuticals with information-rich labelling. 

Cannabis Sativa contains hundreds of cannabinoids, two of which – psychoactive delta-9-tetrahydrocannabinol (THC) and non-psychoactive cannabidiol (CBD) – are important active ingredients in the medical cannabis that are now synthetically manufactured. The cannabis extracts have low water solubility so are only available as oil- or ethanol-based formulations, rather than traditional tablets or capsules. Researchers at the Åbo Akademi University, Finland, and the University of Copenhagen, Denmark, have developed edible pharmaceutical products that contain active cannabinoids, using inkjet printing for the personalisation of each dose.  

Sample Extraction and Analysis

The recent study1 developed data-enriched edible pharmaceuticals (DEEP) with different doses of two cannabinoids, THC and CBD. A cannabinoid-containing ink was imprinted onto freeze-dried porous foams in increasing layers (1-10) using a standard desktop inkjet printer, to incorporate different doses of the lipophilic compounds. The imprint was in the pattern of a personalised QR code to provide relevant patient data and allow for the traceability of the drug at a single dose unit level using a standard smart phone.

The THC and CBD content in the DEEP prior to consumption and during in vitro drug release in saliva samples at 37 °C was analysed using ultra-performance liquid chromatography (UPLC). The analyte solutions were prepared by dissolving the DEEP in 3 ml of acetonitrile and Type I ultrapure water from an ELGA LabWater PURELAB® flex 4. Ultrapure water was also used in the preparation of the polymer substrate. 

The Results

Analysis of the THC and CBD content in the DEEP revealed a strong correlation between the number of printed layers of ink and the concentration of cannabinoids deposited. THC and CBD were successfully imprinted onto the substrate with an average of 0.051 and 0.054 mg per printed layer, respectively. Comparisons between the measured and label-specified quantities demonstrated that the cannabis ink was not affected by the printing process or the UPLC analysis. For DEEP printed with 3-5 layers, the concentration of CBD was still 94 % of the initial concentration after storing in cold and dry conditions for 8 weeks, demonstrating only minor degradation. 

The printed DEEP is suitable for oral administration on or below the tongue as the porous structure allows for the rapid wetting of the substrate. The 10-layer DEEP was found to be an immediate-release formulation; 80 % of the THC and CBD were released in 45 minutes, which is comparable to the marketed drug product Sativex®. All printed substrates could resist handling without breakage to fulfil the requirements of the European Pharmacopeia, and imprinting increased the stiffness and rigidity of the DEEP.  

Informing Future Planning 

The legalisation of cannabis for medical purposes could be effective in treating various diseases, however, doses need to be personalised and monitored to avoid unwanted side effects or drug misuse. Inkjet printing of cannabis-containing ink in the pattern of a QR code can be an effective method for administering personalised doses while including critical patient information and tracking every dose of medical cannabis. This study also highlights the importance of using the correct storage conditions for medical cannabis products to prevent the degradation of light and temperature sensitive cannabinoids. The protocols used in this research will be effective for quantifying the drug content in edible pharmaceuticals, and evaluating the accuracy of methods for administering personalised doses of medical cannabis. 

Why Choose ELGA LabWater in Finland?

The presence of impurities in laboratory water can be a major problem in research experiments, and can seriously compromise results. ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. We believe in providing you with water purification solutions that can meet a wide range of needs and applications, supported by excellent service and support. For more information on our Type I ultrapure water systems, check out our PURELAB Quest, PURELAB Chorus 1 Complete and our PURELAB Flex models. 

Reference:

1. Öblom et al., 2020, 'Data-enriched edible pharmaceuticals (DEEP) of medical cannabis by inkjet printing', International Journal of Pharmaceuticals, 589:119866  
 

Contact our Finnish partners Here

  • Sales Enquiry
  • Richiedi un Preventivo
  • Technical Support
  • Trova un Partner Approvato

Sales Enquiry

Presso ELGA LabWater, abbiamo offerte interessanti e novità sui nostri prodotti e servizi che speriamo possano interessarti. Utilizzeremo le tue informazioni per prevedere cosa potrebbe piacerti. Tratteremo i tuoi dati con rispetto e puoi trovare tutti i dettagli nella nostra Informativa sulla Privacy.

ELGA LabWater collabora con una rete di Partner Approvati. Per rispondere alle tue domande o richieste, potremmo condividere i tuoi dati di contatto con un Partner Approvato, che potrebbe contattarti direttamente.

Desidero ricevere aggiornamenti da ELGA LabWater e dai Partner Approvati ELGA in base ai miei dati.

Richiedi un Preventivo

Presso ELGA LabWater, abbiamo offerte interessanti e novità sui nostri prodotti e servizi che speriamo possano interessarti. Utilizzeremo le tue informazioni per prevedere cosa potrebbe piacerti. Tratteremo i tuoi dati con rispetto e puoi trovare tutti i dettagli nella nostra Informativa sulla Privacy.

ELGA LabWater collabora con una rete di Partner Approvati. Per rispondere alle tue domande o richieste, potremmo condividere i tuoi dati di contatto con un Partner Approvato, che potrebbe contattarti direttamente.

Desidero ricevere aggiornamenti da ELGA LabWater e dai Partner Approvati ELGA in base ai miei dati.

Technical Support

Presso ELGA LabWater, abbiamo offerte entusiasmanti e novità sui nostri prodotti e servizi che speriamo possano interessarti. Utilizzeremo le tue informazioni per prevedere cosa potrebbe piacerti. Tratteremo i tuoi dati con rispetto e puoi trovare i dettagli nella nostra  Informativa sulla privacy.

ELGA LabWater collabora con una rete di Partner Autorizzati. Per poter rispondere alle tue domande o richieste, potremmo condividere i tuoi dati di contatto con un Partner Autorizzato, che potrebbe contattarti direttamente.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater Sede Centrale

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Casi di Studio

  • Abbott Diagnostics
  • DASA Diagnostica Medica
  • NeoDIN Istituto Medico
  • North Staffordshire NHS Trust
  • Scuola Professionale Olsberg

Risorse

  • Informazioni sull'acqua ultrapura
  • Guide e libri bianchi
  • Tecnologie per la purificazione dell'acqua
  • Applicazioni di laboratorio
  • Impurità nell'acqua
  • Latest Blog
  • Che cosa è il carbonio organico totale (TOC)?
  • Che cosa è l'acqua reagente per laboratorio clinico (CLSI)?
  • Purezza dell'acqua - Diversi tipi di acqua pura

© VWS (UK) Ltd. che opera come ELGA LabWater. 2025 - Tutti i diritti riservati.
ELGA è il marchio mondiale dell'acqua di laboratorio di Veolia.

  • Informazioni sull'acqua ultrapura
  • Guide e White Paper
  • Dichiarazioni di conformità legale globale
  • Brevetti
  • Trademarks
  • Impressum
  • Lingua
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Altri Siti Veolia
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies
Elga Veolia
TOP

© 2017 ELGA Veolia